Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$12.4B
sum of reported positions
Reported positions
747
Changes vs prior quarter
730
74 new · 101 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 248 measured positions in 8 quarters, the typical new or larger position finished −0.1 pts against the S&P 500 and 50% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 994K | $144M | 1.2% | |
| 860K | $137M | 1.1% | |
| 262K | $116M | 0.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.1B | $12.4B |
| Positions | 774 | 747 |
| Biggest line | — | Arcosa, Inc. 1% |
| 788K |
| $114M |
| 0.9% |
| 824K | $112M | 0.9% |
| 149K | $109M | 0.9% |
| 286K | $108M | 0.9% |
| 864K | $96.7M | 0.8% |
| 666K | $95M | 0.8% |
| 1.93M | $92.2M | 0.7% |
| 1.05M | $92.1M | 0.7% |
| 262K | $91.8M | 0.7% |
| 3.29M | $86M | 0.7% |
| 866K | $85.4M | 0.7% |
| 1.06M | $84.9M | 0.7% |
| 266K | $83.5M | 0.7% |
| 1.33M | $82.8M | 0.7% |
| 213K | $80.4M | 0.6% |
| 1.32M | $77.7M | 0.6% |
| 842K | $76.4M | 0.6% |
| 1.91M | $75.7M | 0.6% |
| 824K | $74.7M | 0.6% |
| 114K | $73.2M | 0.6% |
| 940K | $70.2M | 0.6% |
| 938K | $69.3M | 0.6% |
Ironwood Pharmaceuticals (IRWD)
19K shares
Myriad Genetics (MYGN)
12K shares
Commerce.Com (CMRC)
19K shares
Niagen Bioscience (NAGE)
12K shares
ESPERION THERAPEUTICS INC NE
2.63M shares in Q1 2026
Veritone (VERI)
1.32M shares in Q1 2026
Blend Labs (BLND)
1M shares in Q1 2026
Par Technology (PAR)
579K shares in Q1 2026
Elanco (ELAN)
470K shares in Q1 2026
Simulations Plus (SLP)
427K shares in Q1 2026
Forward Air (FWRD)
348K shares in Q1 2026
Zymeworks (ZYME)
299K shares in Q1 2026
CENTESSA PHARMACEUTICALS PLC
278K shares in Q1 2026
TransMedics Group, Inc. (TMDX)
244K shares in Q1 2026
OneSpaWorld Holdings Limited (OSW)
215K shares in Q1 2026
AIR LEASE CORP
213K shares in Q1 2026
Delcath Systems (DCTH)
195K shares in Q1 2026
Stratasys (SSYS)
190K shares in Q1 2026
Ats (ATS)
180K shares in Q1 2026
Core Laboratories Inc. (CLB)
179K shares in Q1 2026
Personalis (PSNL)
156K shares in Q1 2026
Idt (IDT)
145K shares in Q1 2026
TAYLOR MORRISON HOME CORP
143K shares in Q1 2026
ASTRONOVA INC
143K shares in Q1 2026
Vertex (VERX)
136K shares in Q1 2026
